Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom and the United States; - subcontracted manufacturing services (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	2L 2L 1L 1L 3L 1.73Cr 3L 17.51L 7L 85.1L 7L 7L 2.95Cr	P/E 2023 *	-	P/E 2024	-77.6x
Enterprise Value	1.16Cr 1.33Cr 1.07Cr 1.01Cr 1.89Cr 125.8Cr 1.9Cr 13Cr 4.95Cr 62Cr 5.01Cr 4.9Cr 214.89Cr	EV / Sales 2023	46.6x	EV / Sales 2024	2.39x
Free-Float	95.95%	Yield 2023 *	-	Yield 2024	-

28/05	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
28/05	Safe Group enters Peru with exclusive distribution agreement
16/03	Changes to the SAFE Board of Directors
17/12	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
17/12	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
01/12	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/25/28	Alert wrongly tagged to Safe SA withdrawn	RE
27/24/27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/24/09	The market burns its idols
05/24/05	Safe: wins its appeal against Neo Medical
28/23/28	Safe: audit initiated for a turnaround plan
16/23/16	Safe Orthopaedics Announces Consolidated Sales Results for the Third Quarter and Nine Months of 2023	CI
06/23/06	Safe Group Launches Rehabilitation Proceedings	MT

22/12	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
17/12	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
17/12	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/24/09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
24/23/24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

28/05	Safe Group s'implante au Pérou avec un accord de distribution exclusif
28/04	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
31/03	SAFE - Forte dynamique de développement au Venezuela
16/03	Evolutions au sein du Conseil d'Administration de SAFE
16/03	SAFE - Modification de la composition du Conseil d'Administration

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Safe Orthopaedics Share Price Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news : Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	59.21T
STRYKER CORPORATION	+3.07%	+1.76%	-16.68%	+4.43%	12TCr
SMITH & NEPHEW PLC	+0.13%	-0.35%	+6.14%	-8.89%	1.29TCr
GLAUKOS CORPORATION	+1.92%	+4.70%	+27.12%	+95.37%	747.97Cr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.48%	-2.01%	-47.19%	-72.29%	405.53Cr
DOUBLE MEDICAL TECHNOLOGY INC.	+1.51%	+1.51%	+16.61%	+34.36%	251.86Cr
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.94%	+7.26%	-16.20%	-16.91%	175.99Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.21%	-3.13%	+0.15%	-19.56%	159.8Cr
L&C BIO CO.,LTD	-7.07%	+7.51%	+169.58%	+141.20%	153.69Cr
Average	+0.05%	-0.60%	+17.44%	+19.71%	1.84TCr
Weighted average by Cap.	+2.53%	-2.06%	-10.60%	+7.20%

	2023	2024
Net sales	58.1L 66.68L 53.56L 50.38L 94.25L 63Cr 94.91L 6.37Cr 2.47Cr 31Cr 2.5Cr 2.45Cr 107.35Cr	50.41L 57.86L 46.47L 43.71L 81.77L 55Cr 82.35L 5.53Cr 2.15Cr 27Cr 2.17Cr 2.13Cr 93Cr
Net income	-21Cr -24Cr -19Cr -18Cr -33Cr -2.22TCr -34Cr -225.32Cr -88Cr -1.1TCr -89Cr -87Cr -3.8TCr	-192.93Cr -221.43Cr -177.85Cr -167.29Cr -312.96Cr -21TCr -315.16Cr -2.12TCr -821.75Cr -10TCr -831.14Cr -813.34Cr -36TCr
Net Debt	27Cr 31Cr 25Cr 23Cr 44Cr 2.93TCr 44Cr 296.59Cr 115.18Cr 1.44TCr 116.5Cr 114Cr 5TCr	1.15Cr 1.32Cr 1.06Cr 99.46L 1.86Cr 124.08Cr 1.87Cr 13Cr 4.89Cr 61Cr 4.94Cr 4.84Cr 211.94Cr